231 related articles for article (PubMed ID: 34171588)
1. Prospective associations of mid-childhood plasma per- and polyfluoroalkyl substances and pubertal timing.
Carwile JL; Seshasayee SM; Aris IM; Rifas-Shiman SL; Claus Henn B; Calafat AM; Sagiv SK; Oken E; Fleisch AF
Environ Int; 2021 Nov; 156():106729. PubMed ID: 34171588
[TBL] [Abstract][Full Text] [Related]
2. Associations between exposure to a mixture of perfluoroalkyl and polyfluoroalkyl substances and age at menarche in adolescent girls utilizing three statistical models.
Guo M; Yu Y; Liu H; Zhu C
Chemosphere; 2023 Sep; 335():139054. PubMed ID: 37247673
[TBL] [Abstract][Full Text] [Related]
3. Early menarche and other endocrine disrupting effects of per- and polyfluoroalkyl substances (PFAS) in adolescents from Northern Norway. The Fit Futures study.
Averina M; Huber S; Almås B; Brox J; Jacobsen BK; Furberg AS; Grimnes G
Environ Res; 2024 Feb; 242():117703. PubMed ID: 37984785
[TBL] [Abstract][Full Text] [Related]
4. Associations of prenatal and postnatal exposure to perfluoroalkyl substances with pubertal development and reproductive hormones in females and males: The HOME study.
Liu Y; Calafat AM; Chen A; Lanphear BP; Jones NY; Cecil KM; Rose SR; Yolton K; Buckley JP; Braun JM
Sci Total Environ; 2023 Sep; 890():164353. PubMed ID: 37225096
[TBL] [Abstract][Full Text] [Related]
5. Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Body Composition From Mid-Childhood to Early Adolescence.
Janis JA; Rifas-Shiman SL; Seshasayee SM; Sagiv S; Calafat AM; Gold DR; Coull BA; Rosen CJ; Oken E; Fleisch AF
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3760-e3770. PubMed ID: 33740056
[TBL] [Abstract][Full Text] [Related]
6. Exposure to Perfluoroalkyl Substances during Fetal Life and Pubertal Development in Boys and Girls from the Danish National Birth Cohort.
Ernst A; Brix N; Lauridsen LLB; Olsen J; Parner ET; Liew Z; Olsen LH; Ramlau-Hansen CH
Environ Health Perspect; 2019 Jan; 127(1):17004. PubMed ID: 30628845
[TBL] [Abstract][Full Text] [Related]
7. Association of perfluoroalkyl and polyfluoroalkyl substances with sex hormones in children and adolescents 6-19 Years of age.
He Y; Hu C; Zhang Y; Fan X; Gao W; Fang J; Wang Y; Xu Y; Jin L
Environ Pollut; 2023 Jul; 329():121707. PubMed ID: 37098366
[TBL] [Abstract][Full Text] [Related]
8. Associations of Prenatal Per- and Polyfluoroalkyl Substance (PFAS) Exposures with Offspring Adiposity and Body Composition at 16-20 Years of Age: Project Viva.
Zhang M; Rifas-Shiman SL; Aris IM; Fleisch AF; Lin PD; Nichols AR; Oken E; Hivert MF
Environ Health Perspect; 2023 Dec; 131(12):127002. PubMed ID: 38054701
[TBL] [Abstract][Full Text] [Related]
9. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFAS) and child executive function and behavioral problems.
Harris MH; Oken E; Rifas-Shiman SL; Calafat AM; Bellinger DC; Webster TF; White RF; Sagiv SK
Environ Res; 2021 Nov; 202():111621. PubMed ID: 34237332
[TBL] [Abstract][Full Text] [Related]
10. Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort.
Preston EV; Hivert MF; Fleisch AF; Calafat AM; Sagiv SK; Perng W; Rifas-Shiman SL; Chavarro JE; Oken E; Zota AR; James-Todd T
Environ Int; 2022 Jul; 165():107335. PubMed ID: 35696844
[TBL] [Abstract][Full Text] [Related]
11. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
[TBL] [Abstract][Full Text] [Related]
12. Per- and Polyfluoroalkyl Substance Plasma Concentrations and Bone Mineral Density in Midchildhood: A Cross-Sectional Study (Project Viva, United States).
Cluett R; Seshasayee SM; Rokoff LB; Rifas-Shiman SL; Ye X; Calafat AM; Gold DR; Coull B; Gordon CM; Rosen CJ; Oken E; Sagiv SK; Fleisch AF
Environ Health Perspect; 2019 Aug; 127(8):87006. PubMed ID: 31433236
[TBL] [Abstract][Full Text] [Related]
13. Association of mode of delivery with offspring pubertal development in Project Viva: a prospective pre-birth cohort study in the USA.
Aris IM; Rifas-Shiman SL; Mínguez-Alarcón L; Sordillo JE; Hivert MF; Oken E; Chavarro JE
Hum Reprod; 2021 Dec; 37(1):54-65. PubMed ID: 34755186
[TBL] [Abstract][Full Text] [Related]
14. Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels.
Mora AM; Fleisch AF; Rifas-Shiman SL; Woo Baidal JA; Pardo L; Webster TF; Calafat AM; Ye X; Oken E; Sagiv SK
Environ Int; 2018 Feb; 111():1-13. PubMed ID: 29156323
[TBL] [Abstract][Full Text] [Related]
15. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFASs) and child cognition.
Harris MH; Oken E; Rifas-Shiman SL; Calafat AM; Ye X; Bellinger DC; Webster TF; White RF; Sagiv SK
Environ Int; 2018 Jun; 115():358-369. PubMed ID: 29705692
[TBL] [Abstract][Full Text] [Related]
16. Prenatal and Childhood Per- and Polyfluoroalkyl Substance (PFAS) Exposures and Blood Pressure Trajectories From Birth to Late Adolescence in a Prospective US Prebirth Cohort.
Zhang M; Aris IM; Lin PD; Rifas-Shiman SL; Brady TM; James-Todd T; Oken E; Hivert MF
J Am Heart Assoc; 2023 Sep; 12(17):e030760. PubMed ID: 37642023
[TBL] [Abstract][Full Text] [Related]
17. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
18. Serum PFAS and Urinary Phthalate Biomarker Concentrations and Bone Mineral Density in 12-19 Year Olds: 2011-2016 NHANES.
Carwile JL; Seshasayee SM; Ahrens KA; Hauser R; Driban JB; Rosen CJ; Gordon CM; Fleisch AF
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3343-e3352. PubMed ID: 35511700
[TBL] [Abstract][Full Text] [Related]
19. PFAS concentrations in early and mid-pregnancy and risk of gestational diabetes mellitus in a nested case-control study within the ethnically and racially diverse PETALS cohort.
Peterson AK; Zhu Y; Fuller S; Feng J; Alexeeff S; Mitro SD; Kannan K; Robinson M; Padula A; Ferrara A
BMC Pregnancy Childbirth; 2023 Sep; 23(1):657. PubMed ID: 37704943
[TBL] [Abstract][Full Text] [Related]
20. Perfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6-9 Years of Age: A Cross-Sectional Analysis within the C8 Health Project.
Lopez-Espinosa MJ; Mondal D; Armstrong BG; Eskenazi B; Fletcher T
Environ Health Perspect; 2016 Aug; 124(8):1269-75. PubMed ID: 26794451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
